Breast disorder
MONDO:0002657A disease involving the breast.
Also known as: breast disease, breast disease or disorder, breast diseases, breast disorder, disease of breast, disease or disorder of breast, disorder of breast
4686 clinical trials for this condition and its sub-types, 25 tagged with Breast disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Breast disorder
-
Breast neoplasm 3,261 trials · 4,628 incl. sub-types
11 sub-types
- Breast cancer 3,492 trials · 4,513 incl. sub-types Sub-types →
- Intraductal breast neoplasm 1 trial · 155 incl. sub-types Sub-types →
- Breast benign neoplasm 11 trials · 20 incl. sub-types Sub-types →
- Breast fibroepithelial neoplasm 0 trials · 10 incl. sub-types Sub-types →
- Breast fibrosis 2 trials
- Benign ductal tumor of breast 0 trials
- Breast granular cell tumor 0 trials
- Breast hemangiopericytoma 0 trials
- Breast myoepithelial tumor 0 trials Sub-types →
- Breast neuroendocrine neoplasm 0 trials Sub-types →
- Nipple neoplasm 0 trials Sub-types →
-
Lactation disease 18 trials · 24 incl. sub-types
2 sub-types
- Galactorrhea 5 trials Sub-types →
- Lactocele 2 trials
-
Hypertrophy of breast 7 trials · 15 incl. sub-types
1 sub-type
- Gynecomastia disorder 6 trials · 8 incl. sub-types Sub-types →
-
Mastitis 11 trials
1 sub-type
- Neonatal infective mastitis 0 trials
-
Breast fibrocystic disease 7 trials · 10 incl. sub-types
2 sub-types
- Non-proliferative fibrocystic change of the breast 0 trials · 2 incl. sub-types Sub-types →
- Breast fibrocystic change, proliferative type 0 trials · 1 incl. sub-types Sub-types →
-
Breast implant illness 8 trials
-
Breast abscess 5 trials
-
Syndromic breast hypoplasia/aplasia 0 trials · 2 incl. sub-types
3 sub-types
- Poland syndrome 2 trials
- Acropectororenal dysplasia 0 trials
- Craniofrontonasal dysplasia-Poland anomaly syndrome 0 trials
-
Breast adenosis 0 trials · 1 incl. sub-types
4 sub-types
- Sclerosing adenosis of breast 1 trial
- Apocrine adenosis of breast 0 trials
- Breast adenomyoepithelial adenosis 0 trials
- Microglandular adenosis of breast 0 trials
-
Isolated congenital breast hypoplasia/aplasia 0 trials · 1 incl. sub-types
3 sub-types
- Amastia 1 trial
- Breasts and/or nipples, aplasia or hypoplasia of, 1 0 trials
- Breasts and/or nipples, aplasia or hypoplasia of, 2 0 trials
-
Benign mammary dysplasia 0 trials
-
Breast angiomatosis 0 trials
-
Fat necrosis of breast 0 trials
-
Supernumerary breasts 0 trials
1 sub-type
- Familial supernumerary nipples 0 trials
Most studied deeper sub-types
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Phase 1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for advanced breast cancer: targeted drug combo tested in major trial
Disease control OngoingThis study tests a new drug called trastuzumab deruxtecan (T-DXd), given alone or with another drug (pertuzumab), against the current standard treatment for HER2-positive breast cancer that has spread. About 1,157 people with this type of cancer will take part. The goal is to see…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a Four-Drug cocktail tame a tough breast cancer?
Disease control OngoingThis trial is testing whether combining four drugs—anastrozole, palbociclib, trastuzumab, and pertuzumab—can safely and effectively treat HR-positive, HER2-positive metastatic breast cancer as a first-line therapy. The study involves people who have not received prior systemic tr…
Phase 1/2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New pill combo aims to outsmart resistant breast cancer
Disease control OngoingThis phase 3 trial tests whether switching to a new oral drug (AZD9833) plus a CDK4/6 inhibitor can delay cancer progression better than staying on standard aromatase inhibitor therapy in people with HR+/HER2- metastatic breast cancer who have an ESR1 mutation. About 315 particip…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Robotic arms take on breast cancer surgery: a new hope for nipple preservation?
Disease control OngoingThis study compares a robotic surgical system (da Vinci SP) to traditional open surgery for nipple-sparing mastectomy in women with early-stage breast cancer. The trial involves 204 participants and will measure safety, cancer recurrence, and patient satisfaction. The goal is to …
Sponsor: Intuitive Surgical • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug duo aims to stall advanced breast cancer
Disease control OngoingThis study tests a new oral drug, camizestrant, combined with palbociclib against the standard anastrozole plus palbociclib in people with ER-positive, HER2-negative advanced breast cancer who haven't had prior treatment for advanced disease. About 1,370 participants will be foll…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a safer, No-Needle MRI replace Dye-Based breast scans?
Diagnosis OngoingThis study is testing whether a special MRI that does not require a contrast dye injection can accurately detect breast cancer or other breast diseases. Over 1,000 women at risk or with suspected breast issues will receive the new MRI alongside standard care. The goal is to see i…
Sponsor: Perspectum • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Could a quick MRI catch more breast cancers in black women?
Diagnosis OngoingThis study is testing whether a fast breast MRI can find cancers that mammograms miss in Black women with dense breast tissue. About 500 African American women who recently had a normal mammogram will get an additional abbreviated MRI. Researchers want to see if this extra scan d…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
New pain drug could ease recovery after breast surgery
Symptom relief By invitation onlyThis study tests whether a painkiller called suzetrigine can reduce pain after breast surgery (not mastectomy). About 120 adults will take the drug along with a nerve block. Their pain levels will be compared to past patients who had standard care. The goal is to see if this comb…
Phase 4 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC